| Component: (Network and Table) | |
|---|---|
| Network | 103 - Statement - Consolidated Balance Sheets (http://www.abiomed.com/taxonomy/role/StatementOfFinancialPositionClassified) |
| Table | Statement [Table] |
| Reporting Entity [Axis] | 0000815094 (http://www.sec.gov/CIK) |
| Legal Entity [Axis] | Entity [Domain] |
| Statement [Line Items] | Period [Axis] | |||
|---|---|---|---|---|
2012-03-31 | 2011-03-31 | 2010-03-31 | 2009-03-31 | |
ASSETS | ||||
Current assets: | ||||
Cash and cash equivalents | 5,990,000 | 5,831,000 | 4,788,000 | 1,785,000 |
Short-term marketable securities | 71,233,000 | 54,481,000 | ||
Accounts receivable, net | 20,458,000 | 15,376,000 | ||
Inventories | 11,142,000 | 7,505,000 | ||
Prepaid expenses and other current assets | 1,716,000 | 1,544,000 | ||
Total current assets | 110,539,000 | 84,737,000 | ||
Property and equipment, net | 6,378,000 | 6,273,000 | ||
Intangible assets, net | 115,000 | 1,632,000 | ||
Goodwill | 36,846,000 | 38,946,000 | ||
Other long-term assets | 33,000 | |||
Total assets | 153,911,000 | 131,588,000 | ||
LIABILITIES AND STOCKHOLDERS' EQUITY | ||||
Current liabilities: | ||||
Accounts payable | 6,910,000 | 6,283,000 | ||
Accrued expenses | 12,480,000 | 14,078,000 | ||
Deferred revenue | 3,025,000 | 1,982,000 | ||
Total current liabilities | 22,415,000 | 22,343,000 | ||
Long-term deferred tax liability | 4,799,000 | 4,010,000 | ||
Other long-term liabilities | 400,000 | 492,000 | ||
Total liabilities | 27,614,000 | 26,845,000 | ||
Commitments and contingencies (Note 10) | xsi:nil | xsi:nil | ||
Stockholders' equity: | ||||
Class B Preferred Stock, $.01 par value Authorized-1,000,000 shares; Issued and outstanding-none | xsi:nil | xsi:nil | ||
Common stock, $.01 par value Authorized-100,000,000 shares; Issued-39,323,708 shares at March 31, 2012 and 37,756,719 shares at March 31, 2011; Outstanding-39,272,754 shares at March 31, 2012 and 37,705,765 shares at March 31, 2011 | 393,000 | 377,000 | ||
Additional paid in capital | 401,771,000 | 379,218,000 | ||
Accumulated deficit | (273,275,000) | (274,770,000) | ||
Treasury stock at cost-50,954 shares | (827,000) | (827,000) | ||
Accumulated other comprehensive (loss) income | (1,765,000) | 745,000 | ||
Total stockholders' equity | 126,297,000 | 104,743,000 | 107,956,000 | 115,983,000 |
Total liabilities and stockholders' equity | 153,911,000 | 131,588,000 | ||